Maria Edebrink
General Counsel at XBRANE BIOPHARMA AB
Net worth: 6 633 $ as of 2024-03-30
Profile
Maria Edebrink currently works at Xbrane Biopharma AB, as Head-Regulatory Affairs & Quality Assurance from 2021.
Ms. Edebrink also formerly worked at Medivir AB, as Head-Regulatory Affairs and AstraZeneca AB, as Head-Regulatory Affairs.
Ms. Edebrink received her graduate degree from the University of Stockholm.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
XBRANE BIOPHARMA AB
0.02% | 2023-09-04 | 235,210 ( 0.02% ) | 6 633 $ | 2024-03-30 |
Maria Edebrink active positions
| Companies | Position | Start |
|---|---|---|
| XBRANE BIOPHARMA AB | General Counsel | 2018-12-31 |
Former positions of Maria Edebrink
| Companies | Position | End |
|---|---|---|
| MEDIVIR AB | General Counsel | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | General Counsel | - |
Training of Maria Edebrink
| University of Stockholm | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MEDIVIR AB | Health Technology |
| XBRANE BIOPHARMA AB | Health Technology |
| Private companies | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Maria Edebrink
